Two of these, EGFR and HER2, which regulate various tumourigenic processes through multiple signalling pathways, including the PI3K/Akt, STAT3 and Ras/Raf/MEK/ERK pathways, have garnered widespread attention in CRC.33, 34. This evidence concerns the gene ERBB2 and colorectal carcinoma.